Harvard Bioscience EPS Ratio 2011-2026 | HBIO

EPS is a measure used to assess the financial stability and profitability of a company. EPS (Earnings Per Share) represents the company's net income divided by the number of its outstanding shares. This measure allows investors and analysts to evaluate the return on investment in the company's stock and compare it to other companies in the industry.

The term earnings per share (EPS) represents the portion of a company's earnings, net of taxes and preferred stock dividends, that is allocated to each share of common stock. The figure can be calculated simply by dividing net income earned in a given reporting period (usually quarterly or annually) by the total number of shares outstanding during the same term. Because the number of shares outstanding can fluctuate, a weighted average is typically used.
Calculated as:
EPS = (Net Income - Dividends on Preffered Stock) / Average Outstanding shares^[1]

EPS can be calculated as a simple ratio of net income to shares, or in various variations, such as diluted EPS, which takes into account the potential issuance of new shares or convertible securities.

A high EPS ratio usually indicates that the company has good profitability and efficiency in utilizing its assets. However, other factors such as sales growth, debt burden, and the company's competitive position should also be considered.

EPS ratio is an important indicator for investors when making decisions to buy or sell a company's stock. It is also used by analysts to assess the financial condition of the company and its potential for growth and development.

Annual EPS Ratio Harvard Bioscience

2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-0.08	-0.23	-0.01	-0.2	-0.12	-0.08	-0.02	-0.13	-0.57	0.07	-0.06	0.09	0.14

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
0.14	-0.57	-0.0923

Quarterly EPS Ratio Harvard Bioscience

2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-0.03	-0.05	-1.14	-	-0.11	-0.07	-0.11	-	-0.03	-0.02	0.01	-	-0.08	0.06	-0.17	-	-	-0.01	-0.02	-	-0.03	-0.04	-0.12	0.02	-0.07	-0.01	-0.06	0.08	-0.01	-0.04	-0.11	0.03	-0.01	-0.01	-0.03	-0.04	-0.05	-0.02	-0.02	-0.51	-0.02	0.01	-0.04	-	0.02	0.03	0.03	-0.02	-0.03	-0.01	-	0.04	-0.01	0.02	0.02	0.03	-	0.05	0.06

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
0.08	-1.14	-0.0528

References

Khan, T. R., Islam, M. R., Choudhury, T. T., & Adnan, A. M. (2014). How earning per share (EPS) affects on share price and firm value.

EPS Ratio of other stocks in the Medical instruments industry

Issuer	EPS Ratio	Price	% 24h	Market Cap	Country
Atrion Corporation ATRI	11	-	-	$ 810 M	USA
Baxter International BAX	-1	$ 20.66	1.27 %	$ 10.5 B	USA
Becton, Dickinson and Company BDX	5.83	$ 205.09	1.16 %	$ 59 B	USA
Ekso Bionics Holdings EKSO	-0.56	$ 8.15	-7.6 %	$ 164 M	USA
iRhythm Technologies IRTC	-3.63	$ 188.16	0.41 %	$ 5.87 B	USA
Masimo Corporation MASI	-5.72	$ 138.18	0.8 %	$ 7.36 B	USA
Haemonetics Corporation HAE	3.33	$ 84.98	2.36 %	$ 4.28 B	USA
OraSure Technologies OSUR	-0.26	$ 2.65	5.38 %	$ 197 M	USA
Alcon ALC	0.77	$ 80.67	-0.38 %	$ 40.4 B	Schweiz
Predictive Oncology POAI	-2.32	$ 6.85	3.24 %	$ 37.4 M	USA
AtriCure ATRC	-0.95	$ 42.59	1.96 %	$ 2 B	USA
electroCore ECOR	-3.42	$ 5.15	6.19 %	$ 28.4 K	USA
ICU Medical ICUI	-4.83	$ 152.88	1.7 %	$ 3.73 B	USA
AngioDynamics ANGO	-0.83	$ 10.02	-8.29 %	$ 409 M	USA
The Cooper Companies COO	1.88	$ 83.38	-0.63 %	$ 16.6 B	USA
Isoray ISR	-1.23	-	0.03 %	$ 108 M	USA
STERIS plc STE	6.24	$ 260.64	0.52 %	$ 25.7 B	USA
Glaukos Corporation GKOS	-2.78	$ 114.49	0.43 %	$ 5.55 B	USA
InfuSystem Holdings INFU	0.07	$ 8.9	-0.11 %	$ 184 M	USA
Repro Med Systems KRMD	-0.3	$ 5.79	3.02 %	$ 264 M	USA
LeMaitre Vascular LMAT	1.96	$ 85.05	1.55 %	$ 1.91 B	USA
Intuitive Surgical ISRG	6.54	$ 586.15	-1.03 %	$ 208 B	USA
Merit Medical Systems MMSI	2.07	$ 93.33	1.83 %	$ 5.43 B	USA
Utah Medical Products UTMD	4.58	$ 58.5	1.39 %	$ 212 M	USA
Nephros NEPH	-0.15	$ 5.07	-1.74 %	$ 52.7 M	USA
Microbot Medical MBOT	-1.05	$ 2.19	3.55 %	$ 22.3 M	Israel
Milestone Scientific MLSS	-0.06	$ 0.29	2.24 %	$ 23.1 M	USA
NeuroMetrix NURO	-3.96	-	5.05 %	$ 9.02 M	USA
Envista Holdings Corporation NVST	-6.5	$ 23.52	2.53 %	$ 4.05 B	USA
Pro-Dex PDEX	2.73	$ 41.83	4.47 %	$ 138 M	USA
Pulse Biosciences PLSE	-0.88	$ 14.71	-3.26 %	$ 707 M	USA
Repligen Corporation RGEN	0.64	$ 165.12	-2.32 %	$ 9.2 M	USA
ResMed RMD	5.34	$ 250.85	1.07 %	$ 36.6 B	USA
BioLife Solutions BLFS	-0.44	$ 24.91	-1.97 %	$ 1.15 B	USA
Stereotaxis STXS	-0.27	$ 2.57	-1.35 %	$ 207 M	USA
Retractable Technologies RVP	-0.4	$ 0.76	-0.53 %	$ 22.8 M	USA
STAAR Surgical Company STAA	-0.41	$ 22.43	1.08 %	$ 1.1 B	USA
Teleflex Incorporated TFX	1.49	$ 110.0	-13.07 %	$ 5.15 B	USA
West Pharmaceutical Services WST	6.75	$ 274.0	-1.62 %	$ 20 B	USA
DENTSPLY SIRONA XRAY	-4.48	$ 12.53	1.25 %	$ 2.55 B	USA